Results from a new small study suggest people aged 50 and older with MS who want to discontinue disease-modifying therapy can do so with cladribine with minimal risk for relapse.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/cladribine-safe-exit-strategy-stopping-dmts-older-ms-2026a100043b?src=rss
Author :
Publish date : 2026-02-09 21:12:00
Copyright for syndicated content belongs to the linked Source.